Invivyd, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for IVVD, updated each market day.
IVVD AI Sentiment
AI predicts Invivyd, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Invivyd, Inc. Common Stock
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Sector
Exchange
Market Cap
$503,390,876
Cap Tier
Employees
122
Headquarters
NEW HAVEN, CT
Listed Since
Aug. 6, 2021
Website
IVVD Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IVVD Volatility
Invivyd, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
